Return to: Academic Health Center : myU : U of M Home

Gold University of Minnesota M. Skip to main content. Link to University of Minnesota homepage
Office for Clinical Research
gray whats inside banner
About the Office

Accelerate
Monthly Newsletter


Contact Us

CTSA Information

Employment Opportunities

Events

For Patients

News

Partner with U

Services

Researcher's Toolbox

 

Clinical Research Home

Home > Researcher's Toolbox > Clinical Research Training > Career Advancement Program for Clinical Research Scholars (CAPS) > Scholar Profiles > Ken Kunisaki, M.D.

Printer-friendly version   Email this page to a friend

Ken Kunisaki, M.D.

CAPS scholar Ken Kunisaki hopes to improve the quality of life for those with chronic obstructive pulmonary disease. COPD is a common, prevalent disease—it is the fourth leading cause of wordwide mortality— with associated exacerbations that often result in emergency room visits or hospitalizations. Unfortunately, there are few clinical options for patients: treatment is largely limited to smoking cessation and a few classes of inhalers.

One area that may provide new treatment is micronutrients—vitamins and minerals the body needs in small amounts. Micronutrients have been found to play critical roles in the regulation and function of multiple, different immune system cells and might protect against infections. “Current data suggest that among the more elderly or ill patients, of whom most patients with COPD would be included, micronutrients could play an important role in protection from infection,” says Kunisaki, assistant professor in the Medical School’s Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine. “This is of particular importance in COPD,” he adds, “as up to 80% of COPD exacerbations are attributed to respiratory infections.”

Kunisaki is currently conducting an observational study at the Minneapolis VA Medical Center, where he has a joint appointment. During the study, he will examine participants’ diets, test for micronutrient blood levels, and observe COPD exacerbation rates. Previous studies have demonstrated that COPD patients have micronutrient deficiencies, but nothing is known about the relationship of these deficiencies and their risk of infections and exacerbations. “This study will provide preliminary data necessary to establish, or refute, the rationale for a clinical trial,” he says.

The CAPS program, which provides 75% protected time, will be instrumental in developing his research and career. “It’s difficult to find funding mechanisms for preliminary studies, especially for those early in their career. This program supports preliminary work and provides an opportunity to develop skills on how to conduct clinical research,” he says.

“The CAPS emphasis on multidisciplinary research is also exciting to me,” he says. While his previous research was narrowly focused on pulmonary medicine, Kunisaki will now extend his work into the broad field of nutritional research. “I am learning how to assess and analyze dietary intakes and how to evaluate micronutrient status of individuals. Also, I am learning how to communicate among disciplines.” Kunisaki’s mentoring team is multidisciplinary: Dennis Niewoehner, M.D., professor and chief of pulmonary medicine at the Minneapolis VA Medical Center; John Connett, Ph.D., professor and division head of biostatistics; and Allen Levine, Ph.D., professor and dean of the College of Food, Agriculture, and Natural Resource Sciences.

Ultimately, Kunisaki hopes this research will clarify the relationship between micronutrients and clinical outcomes of this devastating disease.

Overview

For Applicants

For Scholars

Mentoring

Contacts & Support

Updates & Announcements

Scholar Profiles

Program Evaluation

Frequently Asked Questions


Feedback | Notice of Privacy Practices

 
The University of Minnesota is an equal opportunity educator and employer.